baber/WOPTO huggingface dataset:
Patent WO-2018089887-A3 (WO)
Inventor: SAFABAKHSH MOJTABA
IPC: F16D3/84
Filed: 2017-11-13
Abstract: L'invention concerne un ensemble d'étanchéité monté dans un mécanisme articulé de sorte que le mécanisme articulé puisse s'adapter à des quantités significatives de mouvement angulaire et latéral. L'ensemble d'étanchéité est utilisé pour établir une étanchéité entre une tige d'entrée, reliée au flotteur d'un générateur à houle, et l'espar du générateur à houle.
Patent WO-2018132794-A3 (WO)
Title: Système de suivi de présence et de position dans des installations
Inventor: RAJI REZA
IPC: G01S5/02
Filed: 2018-01-15
Abstract: Selon des modes de réalisation, la présente invention concerne un système comprenant une application mobile configurée pour fonctionner sur une pluralité de dispositifs mobiles, et un réseau de dispositifs comprenant une pluralité de dispositifs installés dans des locaux. Chaque dispositif comprend un dispositif de communication configuré pour communiquer avec la pluralité de dispositifs mobiles au niveau des locaux à l'aide de l'application mobile. Le système comprend une plate-forme en nuage couplée au réseau de dispositifs par l'intermédiaire d'un réseau éloigné. La plate-forme en nuage est éloignée des locaux et comprend un programme de plate-forme configuré pour utiliser des données de réseau de dispositifs en provenance de la pluralité de dispositifs et des données de dispositif mobile en provenance de l'application mobile pour détecter la présence et réaliser un suivi de la position en temps réel de la pluralité de dispositifs mobiles dans les locaux.
Patent WO-2018195375-A3 (WO)
Inventor: DESILETS MARK
IPC: F15B15/26
Filed: 2018-04-20
Abstract: La présente invention concerne un système de positionnement d'un patient avant, pendant ou après un acte médical, qui peut comprendre un ensemble bras et un champ opératoire destiné à être utilisé avec l'ensemble bras. Le champ opératoire peut être conçu pour être placé autour d'un site chirurgical où un acte chirurgical doit être effectué. Le champ opératoire comprend une fenêtre de visualisation transparente, de multiples couvercles de poignée, et une ouverture extensible sur le côté supérieur du champ opératoire. De plus, le champ opératoire peut également comprendre des composants adhésifs sur le côté inférieur du champ qui peuvent être retirés indépendamment afin de fixer le champ autour d'un site chirurgical.
Patent WO-2019147478-A3 (WO)
Title: Programmable protein circuits in living cells
Inventor: GAO XIAOJING
IPC: C12P21/06
Filed: 2019-01-17
Abstract: Some embodiments of the systems, methods and compositions provided herein relate to a compound protease. In some embodiments, the compound protease includes a protease domain and a cut site for another enzyme. In some embodiments, the compound protease includes an association domain. In some embodiments, the compound protease is part of a protein circuit.
Patent WO-2019144038-A3 (WO)
Title: Low power lot booster network
Inventor: LOTTER MICHIEL
IPC: H04W52/00
Filed: 2019-01-18
Abstract: A wireless signal booster system and sensor processor for an IoT network is disclosed. An IoT Node contains one or more sensors, potentially a sensor processor or processing element and an IoT modem that can connect to the internet or a private IoT network to deliver data to an IoT hub application. The IoT node may also include one or more short range wireless links. The IoT node may communicate directly to a base station and through the base station be connected to the IoT network (which could be the Internet). Alternatively, the IoT node may connect to a base station through a repeater.
Patent WO-2020097550-A3 (WO)
Inventor: SINHA VINEET
IPC: G05D23/19
Filed: 2019-11-08
Abstract: L'invention concerne un système de chauffage, ventilation et conditionnement d'air (CVCA) comprenant un dispositif de thermostat sans tête et une unité d'adaptateur. Le dispositif de thermostat sans tête comprend au moins un circuit conçu pour recevoir une entrée de commande provenant d'un dispositif utilisateur par l'intermédiaire d'un réseau sans fil local et générer un signal de commande pour un équipement CVCA sur la base de l'entrée de commande. L'unité d'adaptateur comprend au moins un circuit conçu pour recevoir le signal de commande provenant du dispositif de thermostat sans tête par l'intermédiaire du réseau sans fil local et fournir le signal de commande à l'équipement CVCA pour le fonctionnement de l'équipement CVCA conformément à l'entrée de commande. L'unité d'adaptateur réalise des processus de commande de sauvegarde si une connexion au réseau sans fil local ne peut pas être établie.
Patent WO-2020140121-A3 (WO)
Title: Système de support de trachéostomie
Inventor: VAHABZADEH-HAGH ANDREW
IPC: A61B46/20
Filed: 2019-12-30
Abstract: L'invention concerne des matériaux, des articles, des dispositifs et des procédés de fabrication de ceux-ci qui concernent un système de support de trachéostomie. Le système de support de trachéostomie peut éliminer le couple sur le tube de trachéotomie et décharger la pression provoquée par le tube de trachéotomie sur la peau du cou d'un patient. De plus, le système de support de trachéostomie peut indiquer lorsque la pression ou l'humidité sur la peau est à un niveau dangereux qui peut prédisposer le patient à une ulcération, un claquage ou une infection de la peau du cou. Le système de support de trachéostomie peut être réglé automatiquement par l'intermédiaire d'un système de rétroaction en boucle fermée ou peut être réglé manuellement.
Patent WO-2020118317-A3 (WO)
Title: Système et procédé de transfert d'énergie sans fil utilisant des générateurs thermoélectriques
Inventor: PIGGOTT ALFRED J
IPC: H01M10/655
Filed: 2020-01-21
Abstract: Un système de générateur(s) thermoélectrique(s) TEG est fixé à un arbre rotatif et génère de l'électricité à partir d'énergie rayonnante qui est transmise de manière sensiblement rayonnante dans l'atmosphère par une source stationnaire, au système TEG qui est en rotation avec l'arbre. La rotation de l'arbre fournit un refroidissement au système TEG, mais pas d'énergie thermique. Le système TEG comprend au moins un TEG, chaque TEG étant équipé d'une fenêtre de réception d'énergie et de confinement de chaleur et d'un système de conversion d'énergie combinés au refroidissement par convection contrôlée perfectionné par un flux d'air se déplaçant en réponse à la rotation de l'arbre rotatif. L'invention concerne également des TEGs individuels à refroidissement par convection contrôlée.
Patent WO-2020243572-A3 (WO)
Inventor: ELLEBEDY ALI
IPC: C07K14/00
Filed: 2020-05-29
Abstract: The present invention relates to antibodies against influenza neuraminidase, compositions containing the antibodies and methods of using the antibodies.
Patent WO-2021080694-A3 (WO)
Inventor: LIU NIAN
IPC: H01M10/42
Filed: 2020-09-03
Abstract: Deeply rechargeable battery systems and methods, where a core/shell nanoscale structure provides deeply rechargeable anodes that overcome intrinsic limitations of conventional battery materials that involve soluble intermediates or insulating discharge products. The deeply rechargeable battery systems and methods simultaneously overcome the dilemmas of passivation and dissolution. An ion-sieving concept is applied to a Zn anode that confines larger zincate ions and allows smaller hydroxide ions to permeate, can limit/prevent ZnO dissolution and electrode shape change.
Patent WO-2021222584-A3 (WO)
Title: Inhibition of sars-cov-2 viral entry through administration of lactoferrin and uses thereof
Inventor: WEATHERWAX KEVIN J
IPC: A61K9/00
Filed: 2021-04-29
Abstract: This invention is in the field of medicinal pharmacology. In particular, the present invention relates to pharmaceutical compositions comprising lactoferrin (e.g., naturally occurring lactoferrin, recombinant lactoferrin) which function as inhibitors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral entry into a subject (e.g., human subject). The invention further relates to methods of preventing, treating and/or ameliorating symptoms related to conditions caused by the SARS-CoV-2 virus (e.g., COVID-19), comprising administering to a subject (e.g., human subject) lactoferrin (e.g., naturally occurring lactoferrin, recombinant lactoferrin) (e.g., oral formulation of lactoferrin, intravenous (IV) formulation of lactoferrin) alone or with additional agents (e.g., remdesivir).
Patent WO-2021243148-A3 (WO)
Title: Methods and compositions for treating alcoholic liver disease
Inventor: HAWIGER JACK
IPC: A61K38/00
Filed: 2021-05-28
Abstract: Disclosed are compositions and methods for treating conditions mediated by inflammation such as liver steatosis, steatohepatitis, apoptosis and cirrhosis, thrombocytopenia, hypoglycogenemia, hyperglycemia, and hypertriglyceridemia. In one aspect, the compositions and methods disclosed herein can also be used to enhance clearance of microbes from infected tissues, organs, or systems in a subject. Also disclosed herein are compositions and methods for reducing levels of stress responsive transcription factors and metabolic transcription factors in a cell in a subject with microbial, allergic, autoimmune, metabolic, and posttraumatic inflammation of the liver.
Patent WO-2021247710-A3 (WO)
Inventor: BLURTON-JONES MATHEW
IPC: C12N5/02
Filed: 2021-06-02
Abstract: The present invention relates to the development of and use of genetically modified human differentiated cells coupled with xenotransplantation into animal models to identify injury and disease-specific RNA and/or protein biomarkers. Specifically, the present invention encompasses two complementary methods for biomarker discovery that enable the direct and selective labelling, isolation, and analysis of human-specific RNA and/or proteins from xenotransplantation (or chimeric) animal models. Both methods involve the treatment of animal models with an RNA analog and/or amino acid analog that enables the specific isolation and quantification of human RNAs and/or proteins for the identification of novel human biomarkers for a large array of human injuries and diseases.
Patent WO-2022020652-A3 (WO)
Title: Stapled peptides and methods thereof
Inventor: WHITE BRIAN HALBERT
IPC: C07K7/52
Filed: 2021-07-22
Abstract: Among other things, the present disclosure provides various agents. In some embodiments, provided agents can bind to beta-catenin. In some embodiments, the present disclosure provides technologies for modulating beta-catenin functions. In some embodiments, the present disclosure provides technologies for preventing and/or treating conditions, disorders or diseases associated with beta-catenin. In some embodiments, the present disclosure provides designed amino acids which can provide improved properties and/or activities. In some embodiments, the present disclosure provides agents comprising such amino acids.
Patent WO-2023049758-A3 (WO)
Inventor: JALALI BAHRAM
IPC: H04B10/508
Filed: 2022-09-21
Abstract: Systems and methods for single-shot detection and characterization of pulsed Terahertz waveforms in accordance with embodiments of the invention are described. A terahertz detection system can include orthogonal time stretch data acquisition to provide single¬ shot detection in a data acquisition backend. The system can include an orthogonal camera-based data acquisition back end to provide single-shot detection. Certain embodiments can map temporal information onto the spectrum of a broadband optical pulse via pulse chip modulation. Data acquisition can be performed in a back-end using single-shot orthogonal time stretch data acquisition processes. Phase diversity can be used to overcome frequency fading and provide broadband operation.
Patent WO-2023086796-A3 (WO)
Inventor: UDYAVAR AKSHATA
IPC: A61K35/74
Filed: 2022-11-08
Abstract: Provided are methods for treating cancer by converting tumor-resident macrophages into a hybrid M1/M2 macrophage phenotype; this phenotype has attributes that are advantageous for cancer therapy. Hybrid markers include (lower than M2, higher than Ml): SPP1, CD209, and CD206, and induced markers include MERTK, C1QC, IFNa, IFNb, CXCL10, 4-1BBL, and MYC. The methods include administering a therapeutic that effects the phenotypic conversion. Therapeutics, such as delivery vehicles, including immunostimulatory bacteria with genome modifications, are designed so that they do not induce or result in a sufficient TLR2, TLR4, TLR5 response to inhibit type I IFN. The therapeutics also encode a payload that encodes immunostimulatory proteins, such as a cytokine and a modified cytosolic DNA/RNA sensor that constitutively induces type I IFN, such as a modified STING protein. The combination of payload immunostimulatory proteins and properties of the therapeutic delivery vehicle, upon administration, results in macrophage with the hybrid phenotype. The therapeutics are administered to subjects identified as having tumors that comprise proliferating M2 macrophages.
Patent WO-2023150080-A3 (WO)
Inventor: RUSTOMJI CYRUS
IPC: H01M50/152
Filed: 2023-01-30
Abstract: A cap assembly is disclosed that creates a gas-tight seal with a cell can housing. The cap assembly has an outer surface, an inner surface and a perimeter edge. The cap assembly further includes an electrolyte injection port forming a port opening between the outer surface and the inner surface, a vent constructed to form a vent opening from the inner surface to the outer surface when a vent pressure differential is achieved between an outer surface pressure and an inner surface pressure. The vent is positioned (a) concentric to the electrolyte injection port, and (b) closer to the perimeter edge than the position of the electrolyte injection port.
Patent WO-2023150206-A3 (WO)
Inventor: HENARY MAGED
IPC: C07D401/08
Filed: 2023-02-02
Abstract: The present invention is directed to red-shifted fluorophores, methods of making red-shifted fluorophores, and methods of using red-shifted fluorophores. In some embodiments, the red-shifted fluorophores are cytotoxic, and useful for the treatment of proliferative disorders such as cancer. In some embodiments, the red-shifted flourophores are useful for imaging and diagnostic applications.
Patent WO-2023164715-A3 (WO)
Inventor: ZHU WEI
IPC: A61K31/02
Filed: 2023-02-27
Abstract: Disclosed are amino, halo-substituted cyclopentene, cyclopentane, or 4- methylenecyclopent- l-ene carboxylic acid compounds. The disclosed compounds and compositions thereof may be utilized in methods for modulating human ornithine δ- aminotransferase (hOAT) activity, including methods for treating diseases or disorders associated with hOAT activity or expression such as cell proliferative diseases and disorders.
Patent AT-503925-A4 (AT)
Title: Device for producing a current comprises a counter current heat exchanger having a tube coil consisting of two coaxial corrugated tubes
Inventor: MOSER BURGHARD
IPC: F02G5/04
Filed: 2007-01-03
Abstract: Device for producing a current comprises a counter current heat exchanger having a tube coil (11) consisting of two coaxial corrugated tubes (12, 13). The inner corrugated tube (12) is connected to an exhaust gas line (14) and an annular flow channel (15) is connected to a return (16) of a heat carrier circuit at one end and to a feed (17) of a cooling circuit at the other end between the inner and outer corrugated tubes. Preferred Features: The tube coil of the counter current heat exchanger is placed in a loop below a base plate holding the combustion engine (1) and a generator (2).
Patent EP-1163755-A4 (EP)
Title: Verification of server authorization to provide network resources
Inventor: WASSERMAN STEVEN C
IPC: H04L29/06
Filed: 2000-03-15
Abstract: Systems and methods for verifying the authorization of a server to provide network resources to a client. At selected times, the client asserts an authorization interrupt, which will disable some or all non-essential functions of the client unless the server's authorization is verified within an allotted period of time. The client creates a client message by generating a random number and combining it with a client identifier and a value that specifies the current time. The client message is encrypted and sent to the server. Only authorized servers can decrypt the client message and create an encrypted service message that includes the random number. The service message can also contain an authorization code specifying the services that the client may receive, and an expiration count indicating when the authorization procedure will be repeated. The client receives and decrypts the service message. If the random number in the service message is found to be the same as the random number in the client message, the server is authorized, and the client is enabled to exhibit a selected level of functionality. The client can be associated with a smart card or another intelligent peripheral that verifies the authorization of the server in behalf of the client.
Patent EP-1175182-A4 (EP)
Title: Improved interface for laser eye surgery
Inventor: CLAPHAM TERRANCE N
IPC: A61B18/20
Filed: 2000-03-28
Abstract: A laser surgery system having a computer control system coupled to a laser subsystem and a patient seat. The control system is coupled to the laser through a laser alignment system. The control system can be coupled to the patient seat through a patient alignment system. The control system sends a nominal position signal to move the patient seat, laser subsystem, or both so that the patient's first eye is moved into substantial alignment with the laser beam axis. The control system can send a second nominal signal to move the patient's second eye into substantial alignment with the laser beam axis. The control system can optionally comprise both an operator display and an assistant display. The assistant display provides real-time information to an assistant positioned at an assistant station adjacent the patient seat. The control system can be programmed to display edit fields with different colors to provide an obvious indication of the refractive information of the eye. The control system can comprise an operator input for providing a pre-determined secondary ablative treatment. If it is determined that the first ablative treatment did not completely remove the epithelial layer from a target region, the operator actuates the operator input to deliver the secondary ablative treatment.
Patent EP-1264027-A4 (EP)
Title: Display form having magnetically attachable parts
Inventor: VARNER RICHARD
IPC: F16C11/04
Filed: 2001-01-26
Abstract: Forms for display of clothing and the like with magnetically attachable parts are provided. The magnetic joints comprise a magnetic assembly with a depth-of-pull sufficient to cause the attachable part to begin to pull toward the form at a distance preferably greater than one-half inch, preferably about one inch. Preferably the magnetic assembly has a depth-of-pull of at least about 120 gauss at a distance of one inch. A metallic plate is arranged in mating configuration with the magnetic assembly. Mating pins may be provided, as well as indexing pins. If the manikin is knocked over, or if the attached part is pulled or bumped, it will come loose rather than breaking off; and the mating parts are self-seeking in use, so that they will come together in proper orientation even when being mated beneath clothes. A bump to the manikin sufficient to overcome the on-contact strength of the magnetic attachment may not result in detachment of the limb because of the depth-of-pull strength of the magnetic assembly. The indexing pins allow the limbs to be placed in a variety of positions.
Patent EP-1294236-A4 (EP)
Title: Animal food and method
Inventor: WILSON MARK E
IPC: A23K1/10
Filed: 2001-05-31
Abstract: The present invention is directed to compositions and methods for increasing the reproductive performance of breeding populations of swine. The swine feed compositions of the present invention are animal feed blends including marine animal products such as a fish oil or fish meal products. Methods include administering to the female swine a biologically effective amount of the swine feed composition comprising marine animal products wherein the marine animal products contain omega-3 fatty acids or esters thereof that serve as a source of metabolites in the female swine, to improve reproductive performance of the female swine.
Patent EP-1248640-A4 (EP)
Title: Preparation and xenotransplantation of porcine islets
Inventor: ELLIOTT ROBERT BARTLET
IPC: A61K35/12
Filed: 2001-01-19
Abstract: The invention relates to developments in the treatment of diabetes in mammals. Particularly it relates to a method of preparing a xenotransplantable porcine islet preparation capable upon xenotransplantation of producing porcine insulin in an appropriate recipient mammal, the method including or comprising the steps of: (I) harvesting the pancreas of piglets at or near full term gestation, and (ii) extracting pancreatic β islet cells from the harvested pancreas wherein the islets (at least at some stage in the performance of the method) are exposed to nicotinamide. Further, the invention relates to a method of encapsulation of a xenotransplantable porcine islet preparation, and transplantation of such a preparation, or a capsule containing such a preparation, into an appropriate recipient mammal.
Patent EP-1304915-A4 (EP)
Inventor: SPANGENBERG GERMAN CARLOS
IPC: C12N9/10
Filed: 2001-06-14
Abstract: La présente invention concerne la modification de la biosynthèse de la lignine chez les plantes et plus particulièrement les enzymes impliquées dans le mécanisme de biosynthèse de la lignine et les acides nucléiques codant ces enzymes ; l'élément de régulation et notamment un promoteur capable de provoquer l'expression d'un gène exogène dans des cellules de plante, ces mêmes promoteurs provenant d'un gène codant une enzyme impliquée dans le mécanisme de biosynthèse de la lignine chez les plantes.; des vecteurs comprenant les acides nucléiques et les éléments de régulation selon l'invention, des cellules de plante, des plantes, des graines et d'autres parties de plante transformées avec les éléments de régulation, les acides nucléiques et les vecteurs ainsi que des procédés d'utilisation des acides nucléiques, des éléments de régulation et des vecteurs.
Patent EP-1301146-A4 (EP)
Title: Artificial vascular grafts, and methods of producing and using same
Inventor: FLUGELMAN MOSHE Y
IPC: A61K38/00
Filed: 2001-07-20
Abstract: The present invention provides intravascular prostheses and methods of production and use. An implantable device for treating a vascular disease or disorder includes an intravascular prosthesis containing an inhibitor of smooth muscle cell proliferation and a growth factor. The device can be coated with a biodegradable drug-eluting polymer that is impregnated with the inhibitor of smooth muscle cell proliferation and the growth factor. The device is useful for treating or preventing a vascular disease or disorder such as restenosis, by simultaneously inhibiting vessel blockage and enhancing recovery of the vessel wall following an intravascular intervention.
Patent EP-1312017-A4 (EP)
Inventor: GREENER SHARON
IPC: G06Q30/00
Filed: 2001-07-11
Abstract: L'invention concerne un système et un procédé destinés à mettre en oeuvre une gestion de risque de change de devises en ligne. Voir Figure 6. On détermine un taux de change et un paramètre de tolérance d'une devise par rapport à la monnaie de base. Le taux de change est modifié si un cours au comptant excède la tolérance (616). Il est possible d'utiliser des premier et second paramètres de tolérance respectivement pour des montées et des chutes sur le marché au comptant.